We want to ensure doctors a rapid access to knowledge about the concentration of substances the body produces in response to an acute infection. Join us in ensuring antibiotics are used only when needed!
With our current organization, we have a strong revenue potential as we grow into new markets.
405 million cases are relevant for rapid testing
Our first target market is general practitioners (GPs) in Denmark
We expect a unit price of €20 per test
The Solution
By developing The Uvigga Test, we are shortening the time it takes to get an accurate diagnosis from 48 hours to 30 min.
User involvement is a strategic choice.
At Uvigga Diagnostics, end-users are a central part of our development process - from idea to final product. We believe that involving users leads to the best solutions, which is why we incorporate user insights into every aspect of our work.
”Urinvejsinfektioner er en stor bekymring for brugerne af vores urologi produkter hvorfor optimering og forudsigelse af UTI samt optimering af diagnosticering er en høj prioritet for os. Coloplast og UVIGGA Diagnostics har startet en dialog op omkring om et muligt samarbejde vedrørende udviklingen af en ny diagnostisk test til tidlig opsporing af urinvejsinfektioner (UVI)."
“OneMed, part of Asker Healthcare Group, is the leading healthcare group and distributor of medical technology in Northern Europe. We have been partners to caregivers for almost forty years and are at the heart of the healthcare ecosystem. We see a potential for commercializing the UVIGGA solutions in both B2G and B2B markets and would be interested in bringing it to the market once the solution has been developed and is ready for commercialization.”
"Your study aims to evaluate the diagnostic performance of innovative technologies in real-world clinical settings across the UK, with a projected recruitment of approximately 1100 participants. We believe your test shows significant potential to improve early identification and clinical management of UTIs and would therefore be a strong candidate for inclusion.”
The importance of diagnostic solutions
New national action plan highlights the importance of new diagnostic solutions and will be prioritized.
Interested in investing?
Upcoming Events
| TechBBQ 2026 |
August, 26-27, 2026 |
Copenhagen Bella Center |
| Ignity 2026 | September 10, 2026 | Odense |
1000000+
End-users
If you have any questions? Please contact us.
Line Vigga Kristensen
CEO / CO-FOUNDER
Line@uvigga.com
+45 61 41 73 59
